First Patient Dosed in Neon Therapeutics’ Phase 1b NT-003 Combination Trial of NEO-PV-01 in Metastatic Melanoma – CBI
Homepage /  Press Release /  First Patient Dosed in Neon Therapeutics’ Phase 1b NT-003 Combination Trial of NEO-PV-01 in Metastatic Melanoma

Press Release

First Patient Dosed in Neon Therapeutics’ Phase 1b NT-003 Combination Trial of NEO-PV-01 in Metastatic Melanoma